Appendix 2—table 35. Antihypertensive Non-user Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Antihypertensive Non-Users by BP: Unmatched | Region=NY Antihypertensive Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 203,624 | 100.0% | 189,573 | 93.1% | 14,051 | 6.9% | 27,966 | 100.0% | 13,983 | 50.0% | 13,983 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 811 | 0.4% | 810 | 0.4% | 1 | 0.0% | <0.001 | 2 | 0.0% | 1 | 0.0% | 1 | 0.0% | 1.00 |
| 21-40 | 11,465 | 5.6% | 11,451 | 6.0% | 14 | 0.1% | 28 | 0.1% | 14 | 0.1% | 14 | 0.1% | ||
| 41-50 | 21,923 | 10.8% | 21,762 | 11.5% | 161 | 1.1% | 324 | 1.2% | 163 | 1.2% | 161 | 1.2% | ||
| 51-60 | 48,159 | 23.7% | 46,035 | 24.3% | 2,124 | 15.1% | 4,245 | 15.2% | 2,121 | 15.2% | 2,124 | 15.2% | ||
| 61-70 | 54,929 | 27.0% | 49,409 | 26.1% | 5,520 | 39.3% | 11,027 | 39.4% | 5,512 | 39.4% | 5,515 | 39.4% | ||
| 71-80 | 44,367 | 21.8% | 39,789 | 21.0% | 4,578 | 32.6% | 9,054 | 32.4% | 4,528 | 32.4% | 4,526 | 32.4% | ||
| ≥81 | 21,970 | 10.8% | 20,317 | 10.7% | 1,653 | 11.8% | 3,286 | 11.7% | 1,644 | 11.8% | 1,642 | 11.7% | ||
| Gender | ||||||||||||||
| Female | 120,465 | 59.2% | 107,632 | 56.8% | 12,833 | 91.3% | <0.001 | 25,530 | 91.3% | 12,764 | 91.3% | 12,766 | 91.3% | 0.97 |
| Male | 83,159 | 40.8% | 81,941 | 43.2% | 1,218 | 8.7% | 2,436 | 8.7% | 1,219 | 8.7% | 1,217 | 8.7% | ||
| Insurance | ||||||||||||||
| Commercial | 75,459 | 37.1% | 73,115 | 38.6% | 2,344 | 16.7% | <0.001 | 4,683 | 16.7% | 2,342 | 16.7% | 2,341 | 16.7% | 1.00 |
| Dual | 1,493 | 0.7% | 1,211 | 0.6% | 282 | 2.0% | 554 | 2.0% | 277 | 2.0% | 277 | 2.0% | ||
| Medicaid | 47,516 | 23.3% | 43,809 | 23.1% | 3,707 | 26.4% | 7,295 | 26.1% | 3,648 | 26.1% | 3,647 | 26.1% | ||
| Medicare | 79,156 | 38.9% | 71,438 | 37.7% | 7,718 | 54.9% | 15,434 | 55.2% | 7,716 | 55.2% | 7,718 | 55.2% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 90,617 | 44.5% | 85,875 | 45.3% | 4,742 | 33.7% | <0.001 | 9,461 | 33.8% | 4,728 | 33.8% | 4,733 | 33.8% | 0.95 |
| Yes | 113,007 | 55.5% | 103,698 | 54.7% | 9,309 | 66.3% | 18,505 | 66.2% | 9,255 | 66.2% | 9,250 | 66.2% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 0.95 | 1.60 | 0.96 | 1.60 | 0.81 | 1.60 | <0.001 | 0.81 | 1.59 | 0.81 | 1.58 | 0.81 | 1.59 | 0.92 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.